**Sudeep Pharma Q1 FY27 Performance: Growth Amidst Challenges** Sudeep Pharma delivered a robust start to FY27, with revenue surging 27% YoY to Rs. 158.3 Cr. This growth was broad-based across Pharma, Food & Nutrition, and Specialty Ingredients, demonstrating resilience despite global headwinds like geopolitical issues and supply chain disruptions. The...
Here's a summary of Sudeep Pharma's investor presentation: **Business Performance:** Sudeep Pharma kicked off FY27 with a strong 27% YoY revenue growth, reaching Rs. 158.3 Cr. This broad-based performance was seen across its Pharma, Food & Nutrition, and Specialty Ingredients businesses, despite challenges like geopolitical issues and supply chain disruptions....
Here's a retail-investor-friendly summary of the Sudeep Pharma presentation: **Business Performance:** Sudeep Pharma reported a strong FY26 with a record revenue of ₹642.3 Cr, up 28% YoY. Q4 FY26 revenue also grew 16% YoY to ₹182.3 Cr. This growth was driven by healthy demand across verticals and contributions from the...
